Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2012
11/13/2012US8309121 Dermatological compositions comprising avermectin nanocapsules
11/13/2012US8309119 Drug containing adhesive preparation
11/13/2012US8309118 Mixture containing carrageenan, hydrocolloids; multilayer coatings
11/13/2012US8309117 Method for making medical devices having antimicrobial coatings thereon
11/13/2012US8309113 Porous coating loaded with a liquid or a solid substance
11/13/2012US8309108 Intranasal compositions
11/13/2012US8309107 Stable solutions of orlistat for pharmaceutical dosage forms
11/13/2012US8309106 Composition for repair of defects in osseous tissues
11/13/2012US8309104 Oral controlled release formulation for sedative and hypnotic agents
11/13/2012US8309069 Human serum albumin-free stabilized interferon liquid formulations
11/13/2012US8309063 Stable sunscreen compositions containing zinc oxide
11/13/2012US8309061 Formulations and methods for treating rhinosinusitis
11/13/2012US8309060 Abuse-proofed dosage form
11/13/2012US8309057 Methods for elevating neurotrophic agents
11/13/2012US8308795 Drug-delivery endovascular stent and method of forming the same
11/13/2012US8308794 Instrumented implantable stents, vascular grafts and other medical devices
11/13/2012US8308707 Method and system for drug delivery to the eye
11/13/2012US8308698 Fluid driven medical injectors
11/13/2012US8308672 Device for passively removing a target component from blood or lymph of a vertebrate subject
11/13/2012CA2575758C Coenzyme q10-containing composition
11/13/2012CA2575396C Composition for capsule coating, capsule coating, and capsule using the same
11/13/2012CA2511925C Heterocyclic inhibitors of phosphatases, compositions and uses thereof
11/13/2012CA2502146C Solution formulations of sirolimus and its analogs for cad treatment
11/13/2012CA2481142C Bisphosphonic acids for the treatment and prevention of osteoporosis
11/13/2012CA2454587C Stable lyophilized pharmaceutical formulation of igg antibodies
11/12/2012CA2747509A1 Treatment of pulmonary and pleural fibrosis using hsp27 inhibitors
11/08/2012WO2012151544A1 Micelles for the solubilization of gossypol
11/08/2012WO2012151517A1 Cochleate compositions and methods of making and using same
11/08/2012WO2012151438A1 Antimicrobial silver hydrogel composition for the treatment of burns and wounds
11/08/2012WO2012151427A1 Transdermal compositions of ibuprofen and methods of use thereof
11/08/2012WO2012151252A2 Composition and method for treatment of diabetes
11/08/2012WO2012151237A1 Rapid dissolve tablet compositions for vaginal administration
11/08/2012WO2012151196A1 Drug delivery compositions and methods of use
11/08/2012WO2012151051A1 Excipient compatibility with ezatiostat
11/08/2012WO2012150839A2 Method for microencapsulating phosphatidylserine
11/08/2012WO2012150705A1 Semi-transparent fragrance composition
11/08/2012WO2012150663A1 Improved sugar-coated liposome composition
11/08/2012WO2012150450A1 Oral compositions comprising creatine
11/08/2012WO2012150429A1 Wound treatment
11/08/2012WO2012150412A1 Novel combination of 4-(3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy)benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing same
11/08/2012WO2012150265A1 Fiber comprising a biodegradable polymer
11/08/2012WO2012150255A1 Bis-(alpha-amino-diol-diester) containing polyesteramide for ophtamology
11/08/2012WO2012150246A1 Dosage form for the controlled release of active ingredients
11/08/2012WO2012150131A1 Improved suspension formulation of a corticosteroid for administration by inhalation
11/08/2012WO2012150130A1 A topical formulation comprising a corticosteroid as active ingredient
11/08/2012WO2012125996A9 Denture adhesive remover for intraoral and extraoral use
11/08/2012WO2012124982A3 Oral preparation having an enteric coating
11/08/2012WO2012124973A3 Combined formulation with improved stability
11/08/2012WO2012121971A3 Locally released growth factors to mediate motor recovery after stroke
11/08/2012WO2012105815A9 Biodegradable paox microspheres having cationic properties
11/08/2012WO2012096859A3 Oral dosage forms of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl]-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide
11/08/2012WO2012095746A3 New hard capsules comprising pullulan
11/08/2012WO2012093404A3 Parenteral formulations of levosimendan
11/08/2012WO2012078647A3 Chemical composition to detect and treat amyloid in a patient's brain and retina
11/08/2012WO2012075447A4 Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
11/08/2012WO2012062685A3 Pharmaceutical composition for treating hcv infections
11/08/2012WO2012033987A3 Anti-human folate receptor beta antibodies and methods of use
11/08/2012WO2011128628A3 Gelled oral pharmaceutical compositions
11/08/2012WO2011117651A3 Compositions
11/08/2012WO2006002840A8 Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
11/08/2012US20120283695 Transdermal drug delivery patch and method of controlling drug release of the same by near-ir
11/08/2012US20120283253 Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
11/08/2012US20120283218 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
11/08/2012US20120283205 Compositions and methods of delivery of pharmacological agents
11/08/2012US20120283195 Glycopeptide phosphonate derivatives
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120282472 Embolization
11/08/2012US20120282464 Spherical Protein Particles and Methods of Making and Using Them
11/08/2012US20120282343 Compositions for oral gene therapy and methods of using same
11/08/2012US20120282342 Method for preparing polysaccharide nanocomposite particles and uses of the same
11/08/2012US20120282341 Lipid Formulated Compositions And Methods For Inhibiting Expression Of Eg5 And VEGF Genes
11/08/2012US20120282340 Drug delivery system
11/08/2012US20120282339 Electrolyte purgative
11/08/2012US20120282338 Extended Release Formulation
11/08/2012US20120282337 Modified Release Formulation
11/08/2012US20120282336 Bilayer tablet formulations
11/08/2012US20120282335 Rapidly dispersing granules, orally disintegrating tablets and methods
11/08/2012US20120282334 Process for preparing ajoene from garlic
11/08/2012US20120282333 Delayed release pharmaceutical composition of mesalamine
11/08/2012US20120282332 Composition and method thereof
11/08/2012US20120282331 Mammalian metabolites of steroids
11/08/2012US20120282330 Chinese herbal composition for the treatment of macular degeneration and the process for manufacturing the same
11/08/2012US20120282329 MUC1 Based Glycolipopeptide Vaccine with Adjuvant
11/08/2012US20120282328 Dual action, inhaled formulations providing both an immediate and sustained release profile
11/08/2012US20120282327 Phosphate-containing nanoparticle delivery vehicle
11/08/2012US20120282326 Compositions and methods related to mirna in diabetic conditions
11/08/2012US20120282325 Liposome of irinotecan or its hydrochloride and preparation method thereof
11/08/2012US20120282324 Methods for Promoting the Revascularization and Reenervation of CNS Lesions
11/08/2012US20120282323 Dry Liposomal PVP-iodine Compositions
11/08/2012US20120282322 Cochleate compositions directed against expression of proteins
11/08/2012US20120282319 Lotioned wipe product to reduce adhesion of soils or exudates to the skin
11/08/2012US20120282318 Sheet for corneal transplants
11/08/2012US20120282316 Method of making inorganic porous particles
11/08/2012US20120282312 Active ingredient delivery system
11/08/2012US20120282307 Gastric retained gabapentin dosage form
11/08/2012US20120282306 Polymer-agent conjugates, particles, compositions, and related methods of use
11/08/2012US20120282305 Biological surfactants for connection to silicone-based materials and modulating levels of immunologically active proteins
11/08/2012US20120282304 Multi-coated lactic acid bacteria and preparing method thereof
11/08/2012US20120282303 Percutaneous absorption preparation comprising anti-dementia drug
11/08/2012US20120282302 Biomaterial composite composition and method of use
1 ... 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 ... 2991